306 related articles for article (PubMed ID: 32220072)
1. Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis.
Wong A; Zhu D; Kraus D; Tham T
Laryngoscope; 2021 Feb; 131(2):333-341. PubMed ID: 32220072
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
Findlay M; White K; Lai M; Luo D; Bauer JD
J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
[TBL] [Abstract][Full Text] [Related]
3. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis.
Findlay M; White K; Stapleton N; Bauer J
Clin Nutr; 2021 Apr; 40(4):1711-1718. PubMed ID: 32994071
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost.
Findlay M; Brown C; De Abreu Lourenço R; White K; Bauer J
J Hum Nutr Diet; 2020 Dec; 33(6):811-821. PubMed ID: 32609428
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
6. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer.
Yamahara K; Mizukoshi A; Lee K; Ikegami S
Auris Nasus Larynx; 2021 Oct; 48(5):1013-1022. PubMed ID: 33883097
[TBL] [Abstract][Full Text] [Related]
10. Association Between Sarcopenia and Mortality in Patients Undergoing Surgical Excision of Head and Neck Cancer.
Stone L; Olson B; Mowery A; Krasnow S; Jiang A; Li R; Schindler J; Wax MK; Andersen P; Marks D; Achim V; Clayburgh D
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):647-654. PubMed ID: 31169874
[TBL] [Abstract][Full Text] [Related]
11. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.
Zhu Y; Guo X; Zhang Q; Yang Y
PLoS One; 2022; 17(6):e0270332. PubMed ID: 35749415
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
Yoon JK; Jang JY; An YS; Lee SJ
PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia in head and neck cancer: A scoping review.
Jovanovic N; Chinnery T; Mattonen SA; Palma DA; Doyle PC; Theurer JA
PLoS One; 2022; 17(11):e0278135. PubMed ID: 36441690
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis.
Takenaka Y; Takemoto N; Oya R; Inohara H
PLoS One; 2021; 16(10):e0259288. PubMed ID: 34714876
[TBL] [Abstract][Full Text] [Related]
18. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
[TBL] [Abstract][Full Text] [Related]
19. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy.
Bentahila R; Giraud P; Decazes P; Kreps S; Nay P; Chatain A; Fabiano E; Durdux C
Cancer Med; 2023 Feb; 12(4):4170-4183. PubMed ID: 36263581
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia predicts overall survival in patients with malignant hematological diseases: A meta-analysis.
Surov A; Wienke A
Clin Nutr; 2021 Mar; 40(3):1155-1160. PubMed ID: 32768316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
